Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonkovsky

Showing results (311-320 of 351) with videos related to

Pageof 36
Sort By:
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Hepatology (Baltimore, Md.)|September 4, 2010
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak, Pierre Brissot, Mark Wurster, et al.
Hepatology (Baltimore, Md.)|September 17, 2013
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associationsDavid E Kleiner, Naga P Chalasani, William M Lee, et al.
Journal of Hepatology|July 19, 2015
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearanceThomas R O'Brien, Ruth M Pfeiffer, Ashley Paquin, et al.
Clinical and Experimental Immunology|November 25, 2014
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitisD M Foureau, T L Walling, V Maddukuri, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trialAnna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Pageof 36

Showing results (311-320 of 351) with videos related to

Sort By:
Pageof 36
Hepatology (Baltimore, Md.)|June 22, 2010
Outcome of sustained virological responders with histologically advanced chronic hepatitis CTimothy R Morgan, Marc G Ghany, Hae-Young Kim, et al.
Hepatology (Baltimore, Md.)|September 4, 2010
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak, Pierre Brissot, Mark Wurster, et al.
Hepatology (Baltimore, Md.)|September 17, 2013
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associationsDavid E Kleiner, Naga P Chalasani, William M Lee, et al.
Journal of Hepatology|July 19, 2015
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearanceThomas R O'Brien, Ruth M Pfeiffer, Ashley Paquin, et al.
Clinical and Experimental Immunology|November 25, 2014
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitisD M Foureau, T L Walling, V Maddukuri, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trialAnna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Pageof 36